Frazier Kenneth C
- SEC CIK
- 0001181175
In the past year, 1 open-market purchase filing worth $2.00M and no sales.
Current role at each company
- EIKN Eikon Therapeutics, Inc.Directoras of Mar 4, 2026
- MRK Merck & Co., Inc.Executive Chairas of Nov 8, 2022
- XOM ExxonMobil Holdings CorpDirectoras of May 26, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- $2.00M
- 1 filing
- Sold
- –
- 0 filings
- Net
- +$2.00M
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Frazier Kenneth C as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
EIKN Eikon Therapeutics, Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 6, 2026 (view filing) | Feb 4 | 2 days | Frazier Kenneth CDirector | PPurchase | +111.1K | $18.00 | +$2.00M | New position111.1K after |
MRK Merck & Co., Inc.
Executive Chair5 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 8, 2022 (view filing) | Nov 7 | 1 day | Frazier Kenneth CExecutive Chair | SSale | −235.8K | $99.55 | −$23.5M | −25.2%700.7K after | 3 lots |
| Nov 7, 2022 (view filing) | Nov 3-4 | 4 days | Frazier Kenneth CExecutive Chair | SSale | −470.0K | $98.66 | −$46.4M | −40.1%700.7K after | 4 lots |
| Nov 3, 2022 (view filing) | Nov 1-2 | 2 days | Frazier Kenneth CExecutive Chair | SSale | −600.0K | $99.86 | −$59.9M | −46.1%700.7K after | 5 lots |
| Nov 1, 2022 (view filing) | Oct 28-31 | 4 days | Frazier Kenneth CExecutive Chair | SSale | −867.1K | $100.44 | −$87.1M | −55.1%706.3K after | 5 lots |
| Nov 10, 2021 (view filing) | Nov 9 | 1 day | Frazier Kenneth CExecutive Chair | SSale | −663.9K | $82.27 | −$54.6M | −53.1%586.8K after | 2 lots |